SCHEMBL20122467

SCHEMBL20122467

Cc1oc(=O)oc1COC(=O)SC[C@H](NC(=O)C(C)(C)SC(=O)OCc1oc(=O)oc1C)C(=O)OCc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ CHRM1 P11229 1/20 0.34
▸ TBXA2R P21731 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ FNTA P49354 1/20 0.34
▸ FNTB P49356 1/20 0.34
▸ ATM Q13315 1/20 0.33
▸ FOLH1 Q04609 1/20 0.33
▸ CTSK P43235 2/20 0.32
▸ PPARA Q07869 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ABCC3 O15438 1/20 0.32
▸ NR1I2 O75469 1/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122464 0.92 — —
SCHEMBL20122493 0.90 ACE (0.39) TACR1POLBCHRM1TBXA2RADRA1A
SCHEMBL20122529 0.90 TACR1 (0.37) TACR1POLBCHRM1TBXA2RADRA1A
SCHEMBL20122469 0.89 CHRM1 (0.34) CHRM1TBXA2RADRA1AATMFOLH1
SCHEMBL20122515 0.88 ADRB2 (0.33) CHRM1TBXA2RADRA1AFOLH1
SCHEMBL20122427 0.88 CYP1A2 (0.33) CYP1A2CYP2C9CYP2C19
SCHEMBL20122425 0.87 FOLH1 (0.32) CHRM1TBXA2RADRA1AFOLH1
SCHEMBL20122424 0.85 CYP1A2 (0.30) CYP1A2CYP2C9CYP2C19
SCHEMBL20122548 0.84 — —
SCHEMBL20122542 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback